vs
Side-by-side financial comparison of Prenetics Global Ltd (PRE) and SolarMax Technology, Inc. (SMXT). Click either name above to swap in a different company.
Prenetics Global Ltd is the larger business by last-quarter revenue ($92.0M vs $46.6M, roughly 2.0× SolarMax Technology, Inc.).
Prenetics (NASDAQ:PRE) is a health sciences company headquartered in Hong Kong, with a presence in the United States. It focuses on early detection, prevention, and treatment of diseases, particularly cancer.
SolarMax Technology, Inc. develops, manufactures and sells high-efficiency solar PV modules and clean energy systems. It serves residential, commercial and industrial clients in North America and key Asia-Pacific markets, offering installation and after-sales support to boost low-carbon energy use.
PRE vs SMXT — Head-to-Head
Income Statement — Q1 FY2023 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $92.0M | $46.6M |
| Net Profit | — | $-872.2K |
| Gross Margin | 39.2% | 2.7% |
| Operating Margin | — | -2.7% |
| Net Margin | — | -1.9% |
| Revenue YoY | — | 623.5% |
| Net Profit YoY | — | 77.7% |
| EPS (diluted) | — | $-0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $46.6M | ||
| Q3 25 | — | $30.6M | ||
| Q2 25 | — | $6.9M | ||
| Q1 25 | — | $6.9M | ||
| Q4 24 | — | $6.4M | ||
| Q3 24 | — | $6.3M | ||
| Q1 23 | $92.0M | — | ||
| Q3 22 | $74.7M | — |
| Q4 25 | — | $-872.2K | ||
| Q3 25 | — | $-2.3M | ||
| Q2 25 | — | $-1.9M | ||
| Q1 25 | — | $-1.3M | ||
| Q4 24 | — | $-3.9M | ||
| Q3 24 | — | $-9.6M | ||
| Q1 23 | — | — | ||
| Q3 22 | — | — |
| Q4 25 | — | 2.7% | ||
| Q3 25 | — | 3.1% | ||
| Q2 25 | — | 8.8% | ||
| Q1 25 | — | 20.5% | ||
| Q4 24 | — | 14.5% | ||
| Q3 24 | — | 19.9% | ||
| Q1 23 | 39.2% | — | ||
| Q3 22 | 34.5% | — |
| Q4 25 | — | -2.7% | ||
| Q3 25 | — | -6.9% | ||
| Q2 25 | — | -25.7% | ||
| Q1 25 | — | -16.7% | ||
| Q4 24 | — | -27.9% | ||
| Q3 24 | — | -158.4% | ||
| Q1 23 | — | — | ||
| Q3 22 | -7.2% | — |
| Q4 25 | — | -1.9% | ||
| Q3 25 | — | -7.4% | ||
| Q2 25 | — | -27.6% | ||
| Q1 25 | — | -18.7% | ||
| Q4 24 | — | -60.6% | ||
| Q3 24 | — | -152.0% | ||
| Q1 23 | — | — | ||
| Q3 22 | — | — |
| Q4 25 | — | $-0.02 | ||
| Q3 25 | — | $-0.04 | ||
| Q2 25 | — | $-0.04 | ||
| Q1 25 | — | $-0.03 | ||
| Q4 24 | — | $-0.07 | ||
| Q3 24 | — | $-0.21 | ||
| Q1 23 | — | — | ||
| Q3 22 | — | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $8.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | — | $-12.2M |
| Total Assets | — | $91.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $8.0M | ||
| Q3 25 | — | $5.7M | ||
| Q2 25 | — | $1.9M | ||
| Q1 25 | — | $6.8M | ||
| Q4 24 | — | $7.1M | ||
| Q3 24 | — | $8.6M | ||
| Q1 23 | — | — | ||
| Q3 22 | — | — |
| Q4 25 | — | $-12.2M | ||
| Q3 25 | — | $-11.8M | ||
| Q2 25 | — | $-15.1M | ||
| Q1 25 | — | $-15.9M | ||
| Q4 24 | — | $-15.1M | ||
| Q3 24 | — | $-10.9M | ||
| Q1 23 | — | — | ||
| Q3 22 | — | — |
| Q4 25 | — | $91.3M | ||
| Q3 25 | — | $58.7M | ||
| Q2 25 | — | $38.2M | ||
| Q1 25 | — | $38.6M | ||
| Q4 24 | — | $38.6M | ||
| Q3 24 | — | $43.0M | ||
| Q1 23 | — | — | ||
| Q3 22 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-2.5M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-2.5M | ||
| Q3 25 | — | $3.4M | ||
| Q2 25 | — | $220.7K | ||
| Q1 25 | — | $-601.1K | ||
| Q4 24 | — | $-1.3M | ||
| Q3 24 | — | $203.6K | ||
| Q1 23 | — | — | ||
| Q3 22 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.0% | ||
| Q1 23 | — | — | ||
| Q3 22 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PRE
Segment breakdown not available.
SMXT
| Yabucoa | $35.9M | 77% |
| Other | $10.7M | 23% |
